In one study of 803 participants, constipation was a reported side effect in nearly a quarter (24%) of people taking semaglutide
Sandra Christensen on The GLP-1 Podcast Show, available on all major platforms
He firmly believes in educating the patient about the importance of good nutrition, hormone balance, stress management, and regular exercise is the key to aging well and having a high quality of life well into your golden years.
Rossing P, Birkenfeld AL, Fioretto P, et al
Preclinical results in murine models treated with GLP-1RAs suggest that the potential effects of semaglutide in AD may be exerted via impact on several AD-related pathophysiologic processes including neuroinflammatory pathways, vascular and BBB integrity, reduced synaptic loss, and neuroprotection [19, 21, 23,24,25,26, 46,47,48]